Conference presentations

Posters and oral presentations given at scientific meetings.

9 items

All publications and presentations

October 2021
Presentation
Therapeutic benefits of MSC-NTF (NurOwn®) exosomes in acute lung injury models2021 NYSCF ConferenceView source
October 2021
Presentation
CSF biomarker correlations with primary outcome in NurOwn Phase 3 clinical trial2021 Annual NEALS MeetingView source
May 2019
Presentation
Phase 2 open-label, multicenter study of repeated intrathecal administration of autologous MSC-NTF cells in progressive multiple sclerosis2019 Annual CMSC MeetingView source
May 2019
Presentation
Molecular characterization of VEGF secretion by MSC-NTF cells (NurOwn): therapeutic implications in ALS2019 Annual AAN MeetingView source
May 2019
Presentation
Modulation of CSF caspase-3 in MSC-NTF cells (NurOwn) in a Phase 2 ALS study: correlations with CSF biomarkers and clinical response2019 Annual AAN MeetingView source
December 2018
Presentation
A systematic review of enrichment strategies for current clinical trials in ALSInternational Symposium on ALS/MNDView source
October 2018
Presentation
MicroRNA changes in the NurOwn Phase 2 ALS randomized clinical trial: relationship to neuroprotection and innate immunityAnnual NEALS ConferenceView source
April 2018
Presentation
Modulation of CSF miRNAs in ALS Phase 2 study participants treated with MSC-NTF cells (NurOwn)Annual AAN MeetingView source
April 2018
Presentation
NurOwn Phase 2 ALS trial: ALSFRS-R improvement is reflected in subscale domainsAnnual AAN MeetingView source

BrainStorm's autologous MSC-NTF cell therapy (NurOwn^®, debamestrocel) is investigational and has not been approved by the FDA or any other regulatory authority.